PRESS RELEASE

Davao City – NCMB Regional Branch XI successfully launched the “Area-Wide Webinar: An Orientation on the Department of Labor and Employment (DOLE) Livelihood Programs and Covid-19 Vaccination Program” last June 29, 2021 via Zoom.

“The dual-topic webinar was primarily designed to disseminate information pertaining to DOLE’s Department Order 173-17, otherwise known as the Revised Guidelines in the implementation of the DOLE Integrated Livelihood and Emergency Employment Programs (DILEEP), that directs DOLE to provide livelihood assistance especially to individuals and breadwinners who lost their jobs during this pandemic. On another note, the second topic of this seminar seeks to inform the citizens the proven medical effects and practical benefits of vaccination as well as disseminate and appreciate the efforts rendered by our public health servants.” explained Regional Branch Director Aerrine Marie R. Reyes during the conceptualization of the webinar.

The webinar was attended by 48 organized companies, 40 unorganized companies and more than 100 participants. During the webinar’s open forum, the discussion was very lively as many questions were raised by the participants.

“The Kabuhayan Program of DOLE is a grant assistance for capacity building on livelihood and entrepreneurial ventures for vulnerable and marginalized workers. Approved kabuhayan projects includes but not limited to meat processing, garments making, bayong and mat weaving production, chili production and processing, rice and corn milling and manufacturing, steel production, opening of water-refiling station, snacks production, “kakanin” processing and many other projects.” clarified Senior Labor Employment Officer Rodrigo O. Roble, Resource Speaker for the first topic, as he answered some of the questions of the participants.

Dr. Kathryn Uy Roa, member of the Adult Immunization Committee of the Philippine Society for Microbiology and Infectious Diseases and resource speaker for the second topic, thoroughly discussed the efficacies of the different vaccines and the possible reactions of individuals who get vaccinated.

“In one study, a group of people were vaccinated with Pfizer and Moderna, and they were monitored with a weekly swab test for 13 weeks. It was found out the subjects were 90% protected.” Roa explained. She further encouraged the public to protect themselves by being vaccinated. Gary B. Bonghanoy